Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Solon Eiendom ASA : Notice of extraordinary general meeting

Solon Eiendom ASA
Posted on: 15 Feb 18

(Oslo, 15 February 2018) Solon Eiendom ASA (OSE: SOLON), calls for the extraordinary general meeting to be held at the company's offices in Olav Vs gate 5, 0161, Oslo, Norway on 09 March 2018 at 10 am (CET).

The notice convening the extraordinary general meeting, including the agenda and the board's proposals to the matters to be dealt with, is enclosed with this notification and will be sent to all shareholders with known addresses.

Relevant documents referred to in the notice are made available on .

For further information, please contact:

Andreas Martinussen
Chief Executive Officer, Solon Eiendom ASA
Cell Phone: +47 400 00 405

Scott Danielsen
Chief Financial Officer, Solon Eiendom ASA
Cell Phone: +47 952 55 620

About Solon Eiendom ASA
Solon Eiendom is a Norwegian residential real estate development company focusing on the Oslo and Akershus region

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Solon Eiendom ASA via GlobeNewswire

Last updated on: 16/02/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.